Rofim, a France-headquartered startup founded in 2018, is pioneering in the Health Care and Health and Wellness sectors. Offering a secure platform designed for teleexpertise and eDiagnostic collaboration, Rofim connects healthcare professionals both in hospitals and urban settings, thereby enhancing diagnostic processes and patient care delivery.
With a user base comprising over 1,400 establishments and 55,000 medical professionals, Rofim has effectively scaled to process in excess of 250,000 annual medical acts by 2023. Structured around four key modules—teleexpertise, teleconsultation, e-RCP, and Dossier Communicant de Cancérologie—its services support the integration within the existing healthcare network, fostering collaboration across various medical professionals and settings.
The company took a significant step in 2023 by adopting a "Société à Mission" status, reflective of its driving mission: improving global health access through innovative partnerships with health practitioners. Anchored by core values of equality, collaboration, diligence, and integrity, Rofim aims to ensure patients receive timely, suitable care from the right professionals.
In its Series A round, Rofim secured a €5.00M investment on 11 October 2021 from key investors including Orange Ventures MEA, Banque des Territoires, Région Sud Investissement, and Axeltim. This funding enables the startup to further its mission of strengthening the city-hospital relations in both France and internationally.